Nicholas Grund Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for Nicholas Grund.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of Nicholas Grund. Nicholas Grund is a Chief Commercial Officer in AMAG PHARMACEUTICALS INC. ($AVM).

Address: C/O AMAG PHARMACEUTICALS, INC. 1100 WINTER STREET WALTHAM 02451 MA

Companies in which Nicholas Grund is an Insider

AMAG PHARMACEUTICALS INC.

Trading Symbol: AVM
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Nicholas Grund: Chief Commercial Officer
Holdings: 73,787 shares
Latest Transaction: Feb 27 2019

Last 4 weeks trend: STRONG BUY
Last 3 months trend: STRONG BUY View transactions

Last 3 Months Overview:
Buy: 6x
Sell: 4x
Shares Bought: 66,000
Shares Sold: 12,213
Share Difference: +53,787
Value Difference: +$225,449

Latest Insider Trading Transactions of Nicholas Grund

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Feb 27 2019AVMAMAG PHARMACEUTICA ...Grund NicholasChief Commercial Of ...Option ExerciseA15.5125,000387,75025,000
Feb 27 2019AVMAMAG PHARMACEUTICA ...Grund NicholasChief Commercial Of ...GrantA0.0012,000085,78773.8 K to 85.8 K (+16.26 %)
Feb 27 2019AVMAMAG PHARMACEUTICA ...Grund NicholasChief Commercial Of ...GrantA0.0012,000073,78761.8 K to 73.8 K (+19.42 %)
Feb 26 2019AVMAMAG PHARMACEUTICA ...Grund NicholasChief Commercial Of ...Payment of ExerciseF15.5198215,23161,78762.8 K to 61.8 K (-1.56 %)
Jan 08 2019AVMAMAG PHARMACEUTICA ...Grund NicholasChief Commercial Of ...Payment of ExerciseF16.193,55557,55562,76966.3 K to 62.8 K (-5.36 %)
Mar 06 2018AVMAMAG PHARMACEUTICA ...Grund NicholasChief Commercial Of ...Option ExerciseA21.0024,000504,00024,000
Mar 06 2018AVMAMAG PHARMACEUTICA ...Grund NicholasChief Commercial Of ...Payment of ExerciseF21.004,19388,05366,32470.5 K to 66.3 K (-5.95 %)

View all Nicholas Grund insider transactions.